Initial clinical data for BDC-4182 Phase 1 dose escalation study expected in 3Q 2026  Cash balance of $38.8 million as of September 30, 2025 anticipated to fund key milestones into 2027 REDWOOD CITY, ...
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the third quarter ended September 30, 2025. The update, including a webcast slide presentation with additional ...
Q3 2025 Earnings Call Transcript November 6, 2025 Operator: Good morning, ladies and gentlemen, and thank you for standing by ...
Final Phase 1b results presented at World Lung Conference highlight the potential of firmonertinib to address unmet needs in EGFR PACC mutant ...
Cell movement is an essential biological process, whether it's cancer cells metastasizing to other parts of the body or ...
Mutations drive evolution, but they can also be risky. New research led by plant biologists at the University of California, ...
Have you recently moved to a new city or area? Updating your address on e-commerce sites, banks, and other services is ...
Cell growth is the most fundamental process in organisms, yet the way in which metabolism determines its rate has long remained unclear. To decipher this mystery, researchers from Earth-Life Science ...
(Shift), a biotechnology company uncovering the biology of cell rejuvenation to end the morbidity and mortality of aging, today announced the release of new research detailing an improved framework ...
Apple turns to Google for AAI, new iOS update warning, iPhone 16 Pro deals, iPhone 17e leaks, Apple’s Christmas Tree contest ...